Evaluation and Management of Palpitations

1. Initial Clinical Assessment

• History and physical examination are essential first steps – The American College of Cardiology (ACC) recommends obtaining a detailed clinical history, focused physical examination, and a resting 12‑lead ECG for every patient presenting with palpitations, as this triad frequently establishes the diagnosis and guides further management. 1
• Rhythm pattern guides differential diagnosis – Regular palpitations suggest re‑entrant supraventricular tachycardias (e.g., AVNRT, AVRT), whereas irregular palpitations point toward premature beats, atrial fibrillation, or multifocal atrial tachycardia. 2
• Onset/termination characteristics differentiate mechanisms – Abrupt (paroxysmal) onset and termination are typical of re‑entrant tachycardias; gradual acceleration/deceleration favors sinus tachycardia secondary to physiologic stressors (infection, volume loss, hyperthyroidism, anemia). 2
• Syncope prevalence in SVT – Approximately 15 % of patients with supraventricular tachycardia experience syncope, indicating rapid ventricular rates or underlying structural disease. 1
• Family history of sudden cardiac death – A positive family history is an independent predictor of ventricular arrhythmias and sudden death, warranting heightened surveillance. (European Society of Cardiology) 3
• Medication and substance review – Systematic documentation of all prescribed drugs, over‑the‑counter stimulants, caffeine, alcohol, and illicit substances is required to identify potential arrhythmogenic triggers. (ESC) 4
• Physical signs during active tachycardia – Observation of irregular cannon “A” waves in the jugular venous pulse and variable intensity of the first heart sound (S1) strongly suggests a ventricular origin of a regular tachycardia. 1
• Baseline examination findings – An irregular pulse, irregular jugular pulsations, absence of an S4 sound, and signs of structural heart disease, valvular pathology, thyroid disease, or hemodynamic instability should be sought. (ACC) 4

2. Diagnostic Testing

12‑Lead Electrocardiogram

• Universal requirement – The ACC mandates a resting 12‑lead ECG for every patient with palpitations as the first diagnostic test. 1
• Pre‑excitation with regular palpitations – This pattern is presumptive for atrioventricular reciprocating tachycardia (AVRT) and warrants immediate referral to an arrhythmia specialist without waiting for spontaneous documentation. 1
• Pre‑excitation with irregular palpitations – Indicates atrial fibrillation conducting over an accessory pathway; immediate electrophysiology evaluation is required because of sudden‑death risk. 1
• Capture ECG during symptoms – Whenever feasible, obtain a 12‑lead ECG while the patient is symptomatic; automated ECG interpretation systems are unreliable and frequently misdiagnose arrhythmias. (ACC) 1

Ambulatory Rhythm Monitoring

• Frequency‑based selection – Choose monitoring modality according to symptom frequency (e.g., 24‑48 h Holter for several episodes per week; event or wearable loop recorder for infrequent episodes; implantable loop recorder for rare but severe episodes; exercise stress testing for exertional symptoms). (No citation; omitted)

3. Cardiac Imaging

• Transthoracic echocardiography for sustained SVT – The ACC recommends TTE in all patients with documented sustained supraventricular tachycardia to exclude structural heart disease not apparent on history, exam, or ECG. 1

• Specific echocardiographic goals –

  • Assess left‑ventricular systolic function and detect structural abnormalities. (ESC) 3
  • Evaluate for aortic stenosis, hypertrophic cardiomyopathy, and other structural diseases influencing management. (ACC) 1
  • Identify tachycardia‑mediated cardiomyopathy that can develop after weeks‑to‑months of rapid SVT. (ACC & Circulation) 2
  • Measure atrial size and left‑ventricular wall thickness. (ACC) 4

• Transesophageal echocardiography – Reserved for detection of left‑atrial thrombus before cardioversion or when transthoracic imaging is inadequate. (ACC) 4

4. Laboratory Evaluation

• Targeted testing based on clinical suspicion – The ACC advises ordering thyroid function tests, serum electrolytes, complete blood count, and renal/hepatic panels when indicated to uncover metabolic or endocrine contributors to palpitations. 4

5. Advanced Electrophysiologic Assessment

• Electrophysiology study (EPS) – Indicated when atrial fibrillation is precipitated by a supraventricular tachycardia (e.g., AVNRT, AVRT, ectopic atrial tachycardia); catheter ablation of the underlying arrhythmia may prevent recurrent AF. (ACC) 4

6. Immediate Referral Indications

• Urgent specialist referral – The ACC recommends immediate referral to a cardiac arrhythmia specialist for any of the following:
  
  • Wide‑complex tachycardia of unknown origin.
  • All patients with Wolff‑Parkinson‑White syndrome (pre‑excitation plus arrhythmia).
  • Severe symptoms during palpitations (syncope, dyspnea, hemodynamic compromise).
  • Drug resistance or intolerance in narrow‑complex tachycardias.
  • Patients desiring a drug‑free strategy and considering catheter ablation. 1

7. Critical Pitfalls to Avoid

• Do not rely on automated ECG interpretation – Automated systems frequently misdiagnose arrhythmias; manual review by a qualified clinician is essential. (ACC) 1
• Do not delay evaluation of pre‑excitation with irregular palpitations – This scenario represents atrial fibrillation with accessory‑pathway conduction and carries a high risk of sudden death. (ACC) 1
• Do not overlook triggers of sinus tachycardia – Always assess for infection, volume depletion, hyperthyroidism, anemia, or other physiologic stressors. (ACC & Circulation) 2
• Do not assume a benign etiology based solely on young age or absence of structural disease – Supraventricular tachycardia frequently occurs in younger individuals without detectable heart disease but still requires appropriate evaluation. (ACC & Circulation) 1

Workup for Worsening Palpitations

Initial Clinical Assessment

• A detailed clinical history, focused physical examination, and a resting 12‑lead ECG constitute the core of palpitation evaluation and frequently provide a definitive diagnosis. [5][6]
• Regular rhythm with sudden onset/termination strongly suggests an atrioventricular nodal re‑entrant tachycardia (AVNRT) or an atrioventricular re‑entrant tachycardia (AVRT). Irregular rhythm points toward premature beats, atrial fibrillation, or multifocal atrial tachycardia. [6][5]
• Paroxysmal (abrupt) onset of episodes indicates a re‑entrant tachycardia mechanism, whereas gradual acceleration or deceleration is typical of sinus tachycardia and warrants evaluation for underlying stressors such as infection or volume depletion. 5
• Syncope occurs in approximately 15 % of patients with supraventricular tachycardia (SVT) and suggests rapid ventricular rates or underlying structural disease. [5][7]
• Polyuria during palpitations may reflect sustained SVT‑induced atrial natriuretic peptide release. [5][6]
• Sex‑specific risk: Women have twice the risk of paroxysmal supraventricular tachycardia compared with men; AVNRT is more prevalent in women and in middle‑aged/older adults. Mean age at symptom onset is 32 ± 18 years for AVNRT and 23 ± 14 years for AVRT. 8

Physical Examination

• Performing the examination during an active tachycardia episode can reveal irregular cannon A waves and variable intensity of the first heart sound (S1), findings that strongly suggest a ventricular origin of a regular tachycardia. [6][7]
• Although physical signs of structural heart disease are often subtle, a focused exam should still be performed to look for overt abnormalities. [6][7]

Diagnostic Testing

12‑Lead Electrocardiogram

• A resting 12‑lead ECG is mandatory for every patient presenting with palpitations. [7][9]
• Pre‑excitation pattern together with paroxysmal regular palpitations is presumptive for AVRT; patients should be referred promptly to an arrhythmia specialist. [7][9]
• Pre‑excitation with irregular palpitations strongly indicates atrial fibrillation conducted over an accessory pathway and requires immediate electrophysiology evaluation because of the risk of sudden death. [7][9]
• Whenever feasible, capture a 12‑lead ECG during symptoms; automated interpretation systems are unreliable and may lead to misdiagnosis. 7

Ambulatory ECG Monitoring (Frequency‑Based Selection)

Selection criteria are based on symptom frequency and severity. [7][10]

Echocardiography

• An echocardiogram is indicated in patients with documented sustained SVT to exclude structural heart disease that cannot be reliably identified by history, physical exam, or ECG alone. [7][10]
• It is essential for detecting valvular aortic stenosis and hypertrophic cardiomyopathy, conditions that may influence arrhythmia management. [5][10]
• Echocardiography also identifies tachycardia‑mediated cardiomyopathy resulting from persistent SVT with a rapid ventricular response. [5][9]

Laboratory Testing

• Thyroid function tests should be ordered when clinical suspicion for thyroid disease exists. 6
• Serum electrolytes are recommended to rule out metabolic contributors to arrhythmia. 10
• A complete blood count may help identify anemia or infection as potential triggers. 7

Advanced Testing (Selective)

• Transesophageal atrial recordings or stimulation are reserved for cases where the clinical history is insufficient or non‑invasive studies are nondiagnostic. 10

Immediate Referral Indications

• Wide‑complex tachycardia of unknown origin warrants urgent referral to a cardiac arrhythmia specialist. [7][10]
• All patients with Wolff‑Parkinson‑White (WPW) syndrome (pre‑excitation plus arrhythmias) should be referred promptly due to the risk of life‑threatening arrhythmias. [7][10]
• Severe symptoms during palpitations (e.g., syncope, dyspnea) require immediate specialist evaluation. [7][10]
• Drug resistance or intolerance in patients with narrow‑complex tachycardias should trigger referral for alternative therapies (e.g., catheter ablation). 7
• Patients desiring freedom from drug therapy should be considered for referral to discuss definitive interventional options. 7

Critical Pitfalls to Avoid

• Do not rely on automatic ECG interpretation systems; they frequently produce incorrect diagnoses. 7
• Do not attribute palpitations to panic or anxiety without proper workup—in a cohort of patients with unrecognized SVT, 67 % met criteria for panic disorder and 54 % had symptoms incorrectly ascribed to stress, especially women. 8
• Do not delay evaluation of pre‑excitation with irregular palpitations; this pattern represents atrial fibrillation with accessory‑pathway conduction and carries a sudden‑death risk. [7][9]
• Do not overlook triggers of sinus tachycardia; always assess for infection, volume loss, or other physiologic stressors. 5

Diagnostic and Initial Management of Palpitations

History and Physical Examination

• The American College of Cardiology advises that every patient with palpitations should undergo a detailed clinical history, focused physical examination, and a resting 12‑lead ECG, as this triad frequently establishes the diagnosis and guides subsequent management. 11
• Regular palpitations with abrupt onset and termination are highly suggestive of atrioventricular nodal re‑entrant tachycardia (AVNRT) or atrioventricular re‑entrant tachycardia (AVRT); irregular palpitations point toward premature beats, atrial fibrillation, or multifocal atrial tachycardia. 11
• Paroxysmal (sudden) onset indicates a re‑entrant tachycardia mechanism, whereas gradual acceleration/deceleration is typical of sinus tachycardia secondary to physiologic stressors such as infection, volume depletion, hyperthyroidism, or anemia. 11
• Syncope occurs in approximately 15 % of patients with supraventricular tachycardia (SVT) and signals rapid ventricular rates or underlying structural heart disease. 12
• Polyuria during an episode may reflect atrial natriuretic peptide release from sustained SVT. 13
• Documented triggers—including caffeine, alcohol, nicotine, recreational drugs, emotional stress, sleep deprivation, exercise, and large meals—should be systematically recorded. 11
• During active tachycardia, the presence of irregular cannon “A” waves in the jugular venous pulse and variable intensity of the first heart sound (S1) strongly suggest a ventricular origin of a regular tachycardia. 11
• Baseline examination should assess for irregular pulse, irregular jugular pulsations, absence of an S4 sound, and signs of structural heart disease, valvular pathology, thyroid disease, or hemodynamic instability. 11

Initial Electrocardiographic Evaluation

• A resting 12‑lead ECG is mandatory for every patient presenting with palpitations and serves as the first diagnostic test. 11
• When pre‑excitation is seen on a resting ECG together with regular palpitations, AVRT is presumptive; immediate referral to an arrhythmia specialist is recommended without waiting for spontaneous documentation. 11
• Pre‑excitation combined with irregular palpitations indicates atrial fibrillation conducting over an accessory pathway; urgent electrophysiology evaluation is required because of the risk of sudden cardiac death. 11
• Whenever feasible, obtain a 12‑lead ECG during active symptoms; automated ECG interpretation systems are unreliable and frequently misdiagnose arrhythmias, so manual review by a qualified clinician is essential. 11

Ambulatory Rhythm Monitoring

• For patients experiencing several episodes per week, a 24‑hour Holter monitor is the preferred modality. 11
• Infrequent episodes are best evaluated with an event recorder or a wearable loop recorder, which are more sensitive than Holter monitoring. 11
• Rare episodes (fewer than two per month) accompanied by severe symptoms or hemodynamic instability warrant implantation of an implantable loop recorder. 11
• Exercise‑triggered palpitations should be investigated with an exercise stress test. 11

Cardiac Imaging

• The American College of Cardiology recommends transthoracic echocardiography for all patients with documented sustained SVT to exclude structural heart disease not detectable by physical examination or ECG. 11
• Echocardiographic assessment should include left‑ventricular systolic function, detection of aortic stenosis, evaluation for hypertrophic cardiomyopathy, measurement of atrial size and left‑ventricular wall thickness, and identification of tachycardia‑mediated cardiomyopathy from persistent rapid SVT. 11
• Transesophageal echocardiography is reserved for detection of left‑atrial thrombus before cardioversion or when transthoracic imaging is inadequate. 14

Laboratory Testing

• Thyroid‑function testing should be performed when clinical suspicion for thyroid disease exists. 11
• Serum electrolytes are obtained to rule out metabolic contributors to arrhythmia. 14
• A complete blood count helps identify anemia or infection as potential triggers. 14
• Renal and hepatic function panels are indicated when suggested by the clinical context. 14

Indications for Immediate Referral to a Cardiac Arrhythmia Specialist

• Wide‑complex tachycardia of unknown origin. 11
• All patients with Wolff‑Parkinson‑White syndrome (pre‑excitation plus arrhythmias) because of the risk of lethal arrhythmias. 11
• Severe symptoms during palpitations (e.g., syncope, dyspnea, hemodynamic compromise). 11
• Drug resistance or intolerance in narrow‑complex tachycardias. 11
• Patients who desire freedom from drug therapy and are candidates for catheter ablation. 11

Critical Pitfalls to Avoid

• Do not rely on automated ECG interpretation; manual review by an experienced clinician is essential. 11
• Do not delay evaluation of pre‑excitation with irregular palpitations, as this represents atrial fibrillation with accessory‑pathway conduction and carries a sudden‑death risk. 11
• Do not overlook physiologic triggers of sinus tachycardia; always assess for infection, volume loss, hyperthyroidism, anemia, or other stressors. 11
• Do not initiate Class I or Class III antiarrhythmic drugs without documented arrhythmia, given the risk of pro‑arrhythmia. 11

Management of Asymptomatic Premature Beats

Diagnostic Evaluation

• A 12‑lead electrocardiogram performed and manually interpreted by a qualified clinician is essential because automated algorithms frequently misclassify premature atrial or ventricular contractions. 15
• Routine laboratory screening—including thyroid‑stimulating hormone, complete blood count, and basic metabolic panel—should be obtained to exclude endocrine, hematologic, or electrolyte contributors to ectopy. 16

Risk Stratification

• High‑risk ECG or clinical features (pre‑excitation patterns, family history of sudden cardiac death, structural heart disease on exam, bundle‑branch block, AV block, or QT interval >460 ms) mandate echocardiography and cardiology referral. [16][15]17
• Low‑risk profile (young adult, normal physical examination, normal ECG, completely asymptomatic) predicts a benign course and does not require antiarrhythmic therapy. 18

Management

Reassurance and Observation

• In patients with isolated premature atrial or ventricular beats, a structurally normal heart, and no symptoms, antiarrhythmic drugs are not indicated because they carry a risk of pro‑arrhythmia and toxicity. [18][19]

Trigger Modification

• Counsel patients to reduce or eliminate caffeine, alcohol, nicotine, and stimulant medications; ensure adequate sleep and stress management; and treat any identified secondary causes (e.g., thyroid disease, anemia). 16

Indications for Additional Testing

• Echocardiography is not routinely indicated for asymptomatic isolated premature beats in a young patient with a normal ECG and no exam findings. [16][20]

Follow‑Up

• Routine follow‑up is unnecessary unless the patient develops symptoms or laboratory testing reveals abnormalities requiring treatment. 18
• Patients should be instructed to seek urgent evaluation if they experience syncope, presyncope, sustained palpitations (>30 s), rapid irregular palpitations suggestive of atrial fibrillation, chest pain, or dyspnea. 20

Critical Pitfalls

• Do not prescribe Class I antiarrhythmic agents (e.g., flecainide, propafenone) for asymptomatic premature beats, as they increase mortality in patients with structural heart disease and can cause pro‑arrhythmia even in structurally normal hearts. [17][19]
• Avoid ordering extensive testing (echocardiography, stress testing, Holter monitoring) in truly asymptomatic patients with a normal ECG and examination, to prevent unnecessary costs and false‑positive findings. 18
• Never omit the initial 12‑lead ECG; it remains the single most important test for uncovering high‑risk features. 15
• Always evaluate for secondary causes (thyroid dysfunction, electrolyte disturbances, medication/substance use) before attributing ectopy to a primary cardiac etiology. 16